Ana Catalina Hernandez Padilla

ORCID: 0000-0003-3464-7294
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pneumonia and Respiratory Infections
  • Antimicrobial Resistance in Staphylococcus
  • Nosocomial Infections in ICU
  • Sepsis Diagnosis and Treatment
  • Immune Response and Inflammation
  • Bacterial Identification and Susceptibility Testing
  • Respiratory Support and Mechanisms
  • Ultrasound in Clinical Applications
  • Infective Endocarditis Diagnosis and Management
  • Airway Management and Intubation Techniques
  • Neonatal and Maternal Infections
  • Zoonotic diseases and public health
  • S100 Proteins and Annexins
  • Hemodynamic Monitoring and Therapy
  • Antifungal resistance and susceptibility
  • Cardiac Arrest and Resuscitation
  • COVID-19 Impact on Reproduction
  • Pediatric health and respiratory diseases
  • Antibiotics Pharmacokinetics and Efficacy
  • COVID-19 Clinical Research Studies
  • Meta-analysis and systematic reviews
  • COVID-19 epidemiological studies
  • Hematological disorders and diagnostics
  • Antimicrobial Peptides and Activities
  • Inhalation and Respiratory Drug Delivery

Inserm
2017-2024

Hôpital Dupuytren
2019-2024

Université de Limoges
2017-2024

Centre Hospitalier Universitaire de Limoges
2019-2022

Hôpital Universitaire Dupuytren
2019

Marqués de Valdecilla University Hospital
2017

Instituto de Investigación Marqués de Valdecilla
2017

Bruno François Hasan S. Jafri Jean Chastre Miguel Sánchez García Philippe Eggimann and 95 more Pierre‐François Dequin Vincent Huberlant Lucía Viña Soria Thierry Boulain Cédric Bretonnière Jérôme Pugin Josep Trenado Ana Catalina Hernandez Padilla Omar Ali Kathryn Shoemaker Pin Ren Frank E. J. Coenjaerts Alexey Ruzin Olivier Barraud Leen Timbermont Christine Lammens Vadryn Pierre Yuling Wu Julie Vignaud Susan Colbert Terramika Bellamy Mark T. Esser Filip Dubovsky Marc J. M. Bonten Herman Goossens Pierre‐François Laterre Didier Chochrad Alain Dive Frédéric Forêt Marc A. Simon Herbert Spapen Jacques Créteur Yves Bouckaert Patrick Biston Marc Bourgeois Martin Nováček Tomáš Vymazal Petr Svoboda Jan Pachl Vladimír Šrámek Michal Hanauer Tomas Hruby Martin Balík Tomáš Suchý Alain Lepape Laurent Argaud Frédéric Dailler Arnaud Desachy Christophe Guitton Alain Mercat Ferhat Meziani Jean-Christophe Navellou R. Robert Bertrand Souweine Jean‐Marc Tadié Adel Maamar Djillali Annane Fabienne Tamion Antoine Gros Saad Nseir Carole Schwebel Gilles Francony Jean‐Yves Lefrant Francis Schneider Matthias Gründling J. Motsch Lorenz Reill Caroline Rolfes Tobias Welte Oliver A. Cornely Frank Bloos Maria Deja Katrin Schmidt Frank Wappler Andreas Meier‐Hellmann Apostolos Komnos Vasileios Bekos Vasilios Koulouras Ioanna Soultati Georgios Baltopoulos Georgios Filntisis Epaminondas Zakynthinos Spyros Zakynthinos Ioannis Pnevmatikos Ildikó Krémer Zoltán Szentkereszty Ágnes Sárkány Zsuzsa Marjanek Pedro Henrique de Moura Maria Consuelo Pintado Delgado Juan Carlos Montejo González Paula Ramírez Antonio Torres Martí Juan Carlos Valía José A. Lorente

10.1016/s1473-3099(20)30995-6 article EN publisher-specific-oa The Lancet Infectious Diseases 2021-04-21

BackgroundThe characteristics and course of endotracheal secretions have scarcely been studied in patients under mechanical ventilation (MV) at risk developing ventilator-associated pneumonia (VAP).Research QuestionCan be exhaustively described what is their predictive value for the diagnosis VAP during MV?Study Design MethodsThis single-center prospective study included neuro-injured with neurologic injury requiring MV least 7 days. Patients pulmonary infectious diseases were ineligible....

10.1016/j.chstcc.2024.100075 article EN cc-by CHEST Critical Care 2024-04-27

Urinary tract infection (UTI) is frequently diagnosed in the Emergency Department (ED). Staphylococcus aureus (SA) an uncommon isolate urine cultures (0.5–6% of positive cultures), except patients with risk factors for urinary colonization. In absence factors, community-acquired SA bacteriuria may be related to deep-seated including infective endocarditis. We hypothesized that could a warning microbiological marker unsuspected endocarditis ED. This retrospective chart review consecutive...

10.1186/s12879-019-4106-0 article EN cc-by BMC Infectious Diseases 2019-06-07

ABSTRACT Study Objective: We evaluated the early hemodynamic profile of patients presenting with acute circulatory failure to Emergency Department (ED) using focused echocardiography performed by emergency physicians after a dedicated training program. Methods: Patients ED an any origin were successively examined recently trained physician and expert in critical care echocardiography. Operators independently interpreted online echocardiographic examinations determine leading mechanism...

10.1097/shk.0000000000001449 article EN cc-by-nc-nd Shock 2019-09-17

Abstract During COVID-19, immature granulocyte (IG) concentration is heterogeneous with higher concentrations than those found in bacterial sepsis. We investigated the relationship between IG levels at ICU admission and on days 7 (± 2) 15 associated pulmonary infections intensive care unit (ICU) patients hospitalized for an acute respiratory distress syndrome (ARDS) related to SARS-CoV-2. Patients infection had a peak of IGs. thresholds 18% or 2 G/L allowed discriminating ventilator...

10.1186/s40560-021-00575-3 article EN cc-by Journal of Intensive Care 2021-09-20

More than half of patients under mechanical ventilation in the intensive care unit (ICU) are field-intubated, which is a known risk factor for ventilator associated pneumonia (VAP). We assessed whether field endobronchial intubation (EBI) with development subsequent VAP during ICU stay. This retrospective, nested case-control study was conducted cohort field-intubated admitted to an teaching hospital three-year period. Cases were defined as EBI and controls corresponded proper position...

10.1371/journal.pone.0217466 article EN cc-by PLoS ONE 2019-05-23

In the Emergency Department (ED), early and accurate recognition of infection is crucial to prompt antibiotic therapy but initial presentation patients variable poorly characterized. Lymphopenia commonly associated with bacteraemia poor outcome in intensive care unit patients. The objective this retrospective study was assess prevalence community-acquired a cohort unselected admitted ED undifferentiated symptoms severe lymphopenia.This single-center conducted over 1 year-period before...

10.1186/s12879-022-07295-5 article EN cc-by BMC Infectious Diseases 2022-03-26

Abstract Background Staphylococcus aureus (SA) pneumonia imposes significant morbidity and mortality in mechanically ventilated, intensive care unit (MV ICU) patients despite best clinical care. We assessed efficacy, PK, AT-neutralizing antibodies (AT NAbs), safety of suvratoxumab (suvra) MV ICU subjects the placebo-controlled, randomized Phase 2 SAATELLITE study (NCT02296320; EudraCT 2014-001097-34). Methods Subjects with PCR-confirmed SA colonization lower respiratory tract were to either...

10.1093/ofid/ofz359.144 article EN cc-by-nc-nd Open Forum Infectious Diseases 2019-10-01

Septic patients with worst clinical prognosis have increased circulating immature granulocytes (IG), displaying limited phagocytosis and reactive oxygen species (ROS) production. Here, we developed an

10.1016/j.isci.2024.109825 article EN cc-by-nc-nd iScience 2024-04-26

Abstract Background Patients with lower airway Staphylococcus aureus (SA) colonization are at great risk (> 20%) of early-onset ventilator-associated pneumonia (VAP). Thus, a rapid test is required to identify patients risk. Suvratoxumab (formerly MEDI4893) human monoclonal antibody that neutralizes SA alpha toxin. SAATELLITE, phase 2 study safety and efficacy suvratoxumab for reducing the incidence (NCT02296320) was conducted recently completed within consortium Combatting Bacterial...

10.1093/ofid/ofz360.1840 article EN cc-by-nc-nd Open Forum Infectious Diseases 2019-10-01

Le développement d’anticorps monoclonaux (mAbs) à visée anti-infectieuse s’est accentué ces dix dernières années avec différentes indications thérapeutiques mais principalement pour prévenir les pneumopathies acquises sous ventilation mécanique (PAVM). Cette complication infectieuse demeure une des préoccupations majeures dans services de réanimation où son incidence reste élevée. L’utilisation mAbs apparaît particulièrement adaptée cette indication au vu leur profil sécurité, cibles...

10.37051/mir-00132 article FR Médecine Intensive Réanimation 2022-12-23
Coming Soon ...